amiodarone has been researched along with methylprednisolone in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.85) | 18.7374 |
| 1990's | 3 (11.54) | 18.2507 |
| 2000's | 9 (34.62) | 29.6817 |
| 2010's | 12 (46.15) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bianconi, L; Gardini, E; Minelli, R; Roti, E; Salvi, M | 1 |
| Easley, AR; McManus, BM; Rogers, JG; Windle, JR | 1 |
| Morera, J; Navas, JJ; Ojanguren, I; Parra, O; Ruiz, J | 1 |
| Donado Uña, JR; Echave-Sustaeta, JM; López Encuentra, A | 1 |
| Abe, M; Iida, T; Kawabata, K; Kohno, I; Kugiyama, K; Sawanobori, T; Umetani, K | 1 |
| Moyssakis, I; Papadopoulos, DP; Votteas, VE | 1 |
| Aube, H; Baudouin, N; Besancenot, JF; Blettery, B; Charles, PE; Doise, JM; Muller, G; Piard, F; Quenot, JP | 1 |
| Duverger, V; Merat, S; Perrier, E; Pierret, C; Pons, Y; Tourtier, JP | 1 |
| Adorno, E; Fernández González, F; Fernández González, R; Miranda, S; Nieves, J; Santiago Casiano, M | 1 |
| Casoni, G; Dubini, A; Piciucchi, S; Poletti, V; Ravaglia, C; Tomassetti, S | 1 |
| Christ, M; Flömer, F; Lussi, C | 1 |
| Campi, I; Fugazzola, L; Groppelli, A; Parati, G; Perego, GB; Persani, L; Ravogli, A | 1 |
| Bartalena, L; Bogazzi, F; Cappellani, D; Manetti, L; Martino, E; Urbani, C | 1 |
2 review(s) available for amiodarone and methylprednisolone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Recurrent amiodarone lung toxicity after withdrawal of the drug and treatment with corticoids].
Topics: Amiodarone; Dose-Response Relationship, Drug; Humans; Lung Diseases; Male; Methylprednisolone; Middle Aged; Recurrence; Substance Withdrawal Syndrome; Time Factors | 1995 |
1 trial(s) available for amiodarone and methylprednisolone
| Article | Year |
|---|---|
Effect of high-dose intravenous glucocorticoid therapy on serum thyroid hormone concentrations in type 2 amiodarone-induced thyrotoxicosis: an exploratory study.
Topics: Administration, Intravenous; Adult; Aged; Amiodarone; Dose-Response Relationship, Drug; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Pilot Projects; Thyroid Hormones; Thyrotoxicosis | 2020 |
23 other study(ies) available for amiodarone and methylprednisolone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Subclinical hypothyroidism, overt thyrotoxicosis and subclinical hypothyroidism: the subsequent phases of thyroid function in a patient chronically treated with amiodarone.
Topics: Amiodarone; Antibodies; Humans; Hypothyroidism; Male; Methimazole; Methylprednisolone; Middle Aged; Tachycardia, Supraventricular; Thyroglobulin; Thyrotoxicosis; Thyrotropin; Thyroxine; Triiodothyronine | 1992 |
Aspergillus myocarditis presenting as myocardial infarction with complete heart block.
Topics: Aged; Amiodarone; Aspergillosis; Aspergillus flavus; Heart; Heart Block; Humans; Lung Diseases; Male; Methylprednisolone; Myocardial Infarction; Myocarditis; Myocardium; Tachycardia, Supraventricular | 1990 |
Amiodarone toxicity: recurrence of interstitial pneumonitis after withdrawal of the drug.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Male; Methylprednisolone; Middle Aged; Pulmonary Fibrosis; Recurrence | 1989 |
SP-D as a marker of amiodarone-induced pulmonary toxicity.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antigens; Antigens, Neoplasm; Biomarkers; Glucocorticoids; Glycoproteins; Humans; Lung; Lung Diseases, Interstitial; Male; Methylprednisolone; Middle Aged; Mucin-1; Mucins; Pulmonary Surfactant-Associated Protein D; Pulmonary Surfactants; Radiography, Thoracic; Tomography, X-Ray Computed | 2002 |
Polyarteritis nodosa and hypertrophic obstructive cardiomyopathy. A true association?
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Cyclophosphamide; Drug Therapy, Combination; Echocardiography; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Polyarteritis Nodosa; Treatment Outcome; Verapamil | 2004 |
Amiodarone-related acute respiratory distress syndrome following sudden withdrawal of steroids.
Topics: Adrenal Cortex Hormones; Aged; Amiodarone; Anti-Arrhythmia Agents; Bronchoalveolar Lavage Fluid; Fatal Outcome; Humans; Lung; Male; Methylprednisolone; Neutrophils; Papilledema; Pneumonia; Respiration, Artificial; Respiratory Distress Syndrome; Shock, Septic; Staphylococcal Infections | 2006 |
Total thyroidectomy for amiodarone-associated thyrotoxicosis: should surgery always be delayed for pre-operative medical preparation?
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Arrhythmias, Cardiac; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Perchlorates; Postoperative Complications; Potassium Compounds; Preoperative Care; Prospective Studies; Severity of Illness Index; Thyroid Hormones; Thyroidectomy; Thyrotoxicosis; Time Factors; Treatment Outcome | 2012 |
An unexpected side-effect of a commonly used drug.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arthralgia; Biopsy; Drug Eruptions; Drug Substitution; Dyslipidemias; Exanthema; Female; Humans; Hypertension; Hypothyroidism; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methylprednisolone; Skin; Tachycardia, Supraventricular | 2013 |
A case of amiodarone-induced acute fibrinous and organizing pneumonia mimicking mesothelioma.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cryptogenic Organizing Pneumonia; Diagnosis, Differential; Humans; Male; Mesothelioma; Methylprednisolone; Tomography, X-Ray Computed | 2015 |
Crazy Paving Pattern.
Topics: Aged, 80 and over; Amiodarone; Anti-Bacterial Agents; Atrial Fibrillation; Dyspnea; Female; Glucocorticoids; Humans; Methylprednisolone; Pneumonia; Radiography; Tomography, X-Ray Computed | 2018 |
Pulsed intravenous methylprednisolone combined with oral steroids as a treatment for poorly responsive type 2 amiodarone-induced thyrotoxicosis.
Topics: Administration, Intravenous; Aged; Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Humans; Iodine; Male; Methylprednisolone; Middle Aged; Thyroglobulin; Thyroid Function Tests; Thyrotoxicosis; Thyrotropin; Thyroxine; Triiodothyronine | 2019 |